IDiyas

For the Inventor, By the Inventor

Bridgewater, NJ, United States of America

Shu S Yang

USPTO Granted Patents = 16

Average Co-Inventor Count = 3.6

ph-index = 10

Forward Citations = 310(Granted Patents)


Location History:

  • Piscataway, NJ (US) (1977 - 1978)
  • Bridewater, NJ (US) (1989)
  • Bridgewater, NJ (US) (1984 - 1997)

Company Filing History:

goldMedal16 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1977-1997

Loading Chart...
16 patents (USPTO):Explore Patents
1. 5610162 - Ester derivatives of 4-aza-steroids (1997-03-11),
2. 5536727 - 17-Ethers and thioethers of 4-aza-steroids (1996-07-16),
3. 5132463 - 1,3-diaryl cyclopentanes and derivatives thereof as PAF antagonists (1992-07-21),
4. 5120729 - Beta-lactams as antihypercholesterolemics (1992-06-09),
5. 5047420 - 1,3-diaryl cyclopentanes and derivatives thereof as PAF antagonists (1991-09-10),
6. 4983597 - Beta-lactams as anticholesterolemic agents (1991-01-08),
7. 4920106 - Acetylenic cyclic carbonates (1990-04-24),
8. 4847271 - Antihypercholesterolemic .beta.-lactones (1989-07-11),
9. 4816477 - Antihypercholesterolemic .beta.-lactones (1989-03-28),
10. 4806564 - Antihypercholesterolemic beta-lactones (1989-02-21),
11. 4656190 - Indene derivatives and their use as PAF-antagonists (1987-04-07),
12. 4515722 - Phosphatidyl inositol analogs useful as anti-inflammatory/analgesic (1985-05-07),
13. 4474806 - Sulfonyl or carbonyl inositol derivatives useful as (1984-10-02),
14. 4069321 - Blocked cholecalciferol and dihydrotachysterol 3 derivatives (1978-01-17),
15. 4064236 - Peptide carbazates and pharmaceutical composition (1977-12-20),

Title: The Innovative Mind of Shu S. Yang

Introduction

Shu S. Yang is a distinguished inventor based in Bridgewater, NJ, recognized for his substantial contributions to the field of pharmaceuticals. With an impressive portfolio of 16 patents, Yang has significantly impacted the development of new therapeutic compounds.

Latest Patents

Among his latest innovations are patents focused on the chemistry of steroids. Notably, he has developed ester derivatives of 4-aza-steroids and 17-ethers and thioethers of 4-aza-steroids. These inventions enhance the functionality and efficacy of steroidal compounds, potentially leading to advancements in medical treatments.

Career Highlights

Yang is currently associated with Merck & Company, Inc., a leader in the pharmaceutical industry known for its commitment to innovation and scientific research. His work here has allowed him to be at the forefront of drug development, contributing to numerous groundbreaking projects.

Collaborations

Throughout his career, Shu S. Yang has collaborated with notable colleagues such as Yuan-Ching P. Chiang and Michael N. Chang. These partnerships have fostered a collaborative research environment that encourages creativity and the exchange of innovative ideas, further advancing the field.

Conclusion

In conclusion, Shu S. Yang stands out as a significant figure in the realm of pharmaceutical inventions. His work not only demonstrates his inventive prowess but also highlights the importance of collaboration in scientific advancements. As he continues to contribute to the field, his patents will undoubtedly play a crucial role in shaping future medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…